[EN] BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME<br/>[FR] AGONISTE BÊTA-ADRÉNERGIQUE ET PROCÉDÉS D'UTILISATION ASSOCIÉS
申请人:[en]CURASEN THERAPEUTICS, INC.
公开号:WO2022109179A1
公开(公告)日:2022-05-27
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor. Disclosed herein is a compound according to Formula (I) or an optically pure stereoisomer, pharmaceutically acceptable salt, solvate, or prodrug thereof. Further disclosed herein is a compound according to Formula (II) or an optically pure stereoisomer, pharmaceutically acceptable salt, solvate, or prodrug thereof.